Civco Medical Solutions trUpoint ARCH Protura ESTRO Forum

April 15, 2013 — Civco Medical Solutionswill showcase trUpoint Arch, a new stereotactic radiosurgery solution, Protura Robotic Patient Positioning System, and the Universal Couchtop Long Extension, along  with other disease site solutions at the 2nd ESTRO Forum, booth #5200 in Geneva, Switzerland, April 19 to 23 2013.

trUpoint ARCH — CIVCO’s new SRS/SRT solution for head and brain disease sites provides clinicians a simple and manageable patient set-up assuring accuracy and repeatability during treatments. The frameless bridge design effectively stabilizes a patient’s head in a non-invasive, comfortable hold for delivering high radiation doses. Compatible with the Universal Couchtop, Posifix thermoplastic system, AccuForm cushions and Protura Robotic Patient Positioning System, trUpoint Arch provides a comprehensive motion management solution for effective SRS/SRT treatment.

Universal Couchtop Long Extension — The Universal Couchtop Long Extension (UCT LE) facilitates better delivery of dose and target coverage by eliminating the interference of rails and junctions with radiation delivery.[1] The robust and durable UCT LE features a large junction-free and artifact-free treatment area. All four extension options attach and detach with ease. UCT LE allows a more efficient workflow with seamless transition from simulation to treatment provided by dosimetrically matching couchtops. Additionally, the unique profile of the UCT LE allows CIVCO’s SBRT Body Pro-Lok bridges to attach directly to the couchtop, enabling a seamlessly integrated SBRT immobilization platform.

Protura Robotic Patient Positioning System — The Protura system is designed to integrate with existing IGRT solutions and Linac. The system positions the patient with 6 degrees of freedom from outside the treatment room, enabling more accurate treatment and keeps patient positioning and motion management on target.  Protura provides the platform to provide a comprehensive motion management solution for every disease site.

For more information: www.CIVCO.com

[1] Physics in Medicine and Biology, December 7, 2011, Vol 56:23, pp. 7435-7447.

Related Content

News | Quality Assurance (QA)

October 11, 2021 — To maintain safety in radiation therapy (RT), every machine performance and patient delivery ...

Time October 11, 2021
arrow
News | Radiation Therapy

October 7, 2021 — NANOBIOTIX, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time October 07, 2021
arrow
Feature | Radiation Therapy | By Dave Fornell

To maintain safety in radiation therapy (RT), every machine performance and patient delivery measurement must be as ...

Time October 05, 2021
arrow
Feature | Radiation Therapy

September 28, 2021 — New research from Washington University School of Medicine in St. Louis suggests that radiation ...

Time September 28, 2021
arrow
News | Radiation Oncology

September 28, 2021 — The global radiotherapy devices market is expected to grow from $5.44 billion in 2020 to $5.848 ...

Time September 28, 2021
arrow
News | Prostate Cancer

September 24, 2021 — Scientists have identified two subtypes of metastatic prostate cancer that respond differently to ...

Time September 24, 2021
arrow
News | Radiation Therapy

September 24, 2021 — The "Global Surface Guided Radiation Therapy (SGRT) Devices Market, By Device Type (Portable v/s ...

Time September 24, 2021
arrow
News | Lung Imaging

September 23, 2021 — The National Cancer Institute announced that Virginia Commonwealth University Massey Cancer Center ...

Time September 23, 2021
arrow
News | Radiation Oncology

September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatment ...

Time September 21, 2021
arrow
News | Radiation Oncology

September 20, 2021 — The rapid pace of developments in the oncology field, mainly brought by cancer immunotherapy, means ...

Time September 20, 2021
arrow
Subscribe Now